I recently went to Merz's advisory council. They introduced their Belotero hyaluronic acid fillers to a group of US dermatologists and plastic surgeons. We hope that it is FDA approved soon. I got a turn at injecting it in Paris and it is very smooth and may last longer than Restylane and Juvederm, which represent the current generation of hyaluronic acid fillers in the US.
For the European market, they introduced Novabel - an alginate facial shaper that has a duration of effect of at least 12 months. It uses a proprietary technology called Geleon. With their recent Bioform acquisition, Merz is becoming a huge player in the aesthetic marketplace.
According to Merz, they're also introducing a new neurotoxin called Bocouture/XEOMIN, which they bill as "a neurotoxin free of complexing protein, available today to customers outside of the United States for aesthetic and neurological use and currently in phase 3 trials for aesthetic indications in the United States."
We'll keep you updated!
Dr. Jason Pozner
Sanctuary Medical Aesthetic Center, Boca Raton
Sanctuary Plastic Surgery, Boca Raton